Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs.
This report contains market size and forecasts of Preclinical Isolated Organ Perfusion System in Global, including the following market information:
Global Preclinical Isolated Organ Perfusion System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preclinical Isolated Organ Perfusion System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Isolated Heart Perfusion Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preclinical Isolated Organ Perfusion System include World Precision Instruments, Radnoti, MDE GmbH, Harvard Bioscience, EMKA Technologies, Danish Myo Technology, ADInstruments and Experimetria, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preclinical Isolated Organ Perfusion System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preclinical Isolated Organ Perfusion System Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preclinical Isolated Organ Perfusion System Market Segment Percentages, by Type, 2021 (%)
Isolated Heart Perfusion Systems
Isolated Abdominal Organ Perfusion Systems
Isolated Lung Perfusion Systems
Others
Global Preclinical Isolated Organ Perfusion System Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preclinical Isolated Organ Perfusion System Market Segment Percentages, by Application, 2021 (%)
Industrial Laboratories and CROs
Academic and Government Research Institutes
Others
Global Preclinical Isolated Organ Perfusion System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preclinical Isolated Organ Perfusion System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preclinical Isolated Organ Perfusion System revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preclinical Isolated Organ Perfusion System revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
World Precision Instruments
Radnoti
MDE GmbH
Harvard Bioscience
EMKA Technologies
Danish Myo Technology
ADInstruments
Experimetria